Sleep disorders in Wilson's disease

European Journal of Neurology

Volumn 18, Issue 1, 2011, Pages 184-190

  Nevsimalova, S ^a   Buskova, J ^a   Bruha, R ^a   Kemlink, D ^a   Sonka, K ^a   Vitek, L ^a   Marecek, Z ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CENTRAL MILITARY HOSPITAL   (Czech Republic)

Author keywords

Cataplexy; Multiple sleep latency test; Polysomnography; Questionnaire study; Sleep co morbidity; Sleepiness; Wilson's disease

Indexed keywords

PENICILLAMINE; ZINC DERIVATIVE;

ADULT; ARTICLE; CATAPLEXY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; HALLUCINATION; HUMAN; INSOMNIA; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP PATTERN; VIVID DREAM; WILSON DISEASE;

ADULT; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRES; SLEEP DISORDERS;

EID: 78650119776     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03106.x     Document Type: Article

References (27)

1. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344-350.
2. Bull AI, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to Menkes disease gene. Nat Genet 1993; 5: 327-337.
3. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene spectrum of mutations and their consequences. Nat Genet 1995; 9: 210-217.
4. Giadheddu M, Tamburini G, Piga M, et al. Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease. Acta Neurol Scand 2001; 103: 71-81.
5. Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis 2005; 20: 295-302.
6. Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 2005; 64: 1726-1732.
7. Borjigin J, Payne AS, Deng J, et al. A novel pineal night-specific ATPase encoded by the Wilson disease gene. J Neurosci 1999; 19: 1018-1026.
8. Snow BJ, Bhatt M, Martin WR, Li D, Calne DB. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991; 54: 12-17.
9. 123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 1998; 65: 60-64.
10. Oertel WH, Tatsch K, Schwartz J, et al. I-Iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease. Ann Neurol 1992; 32: 743-748.
11. Westermark K, Tedroff J, Thuomas KA, et al. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. Mov Disord 1995; 10: 596-603.
12. Hawkins RA, Mazziotta JC, Phelps ME. Wilson's disease studied with FDG and positron emission tomography. Neurology 1987; 37: 1707-1711.
13. Portala K, Westermark K, Ekselius L, Broman JE. Sleep in patients with treated Wilson's disease. A questionnaire study. Nord J Psychiatry 2002; 56: 291-297.
14. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson's disease. Liver Int 2003; 23: 139-142.
15. Ferenci P. Wilson's disease. Clin Gastroenerol Hepatol 2005; 3: 726-733.
16. Andlin-Sobocki P, Jonsson B, Wittchen H, Olesen J. Cost of disorders of the brain in Europe. Europ J Neurology 2005; 12: 1-27.
17. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540.
18. Roth T, Roehrs TA, Rosenthal L. Measurement of sleepiness and alertness: multiple sleep latency test. In: Chokroverty S ed. Sleep Disorders Medicine. Basic Science, Technical Considerations, and Clinical Aspects. Boston: Butterworth Heinemann, 1999: 223-229.
19. Stiasny-Kolster K, Mayer G, Schäfer S, Mo{double acute}ller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire - a new diagnostic instrument. Mov Disord 2007; 22: 2386-2393.
20. Rechstchaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service - Brain Research Institute, UCLA, 1968.
21. Firneisz G, Szalay F, Halasz P, Komoly S. Hypersomnia in Wilson's disease: an usual symptom in an unusual case. Acta Neurol Scand 2000; 101: 286-288.
22. Mahowald MW, Schenck CH. REM sleep parasomnias. In: Kryger MH, Roth T, Dement WC eds. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders, 2005: 897-916.
23. Spisni E, Valeri MC, Manerba M, et al. Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. Neurotoxicology 2009; 30: 605-612.
24. Barthel H, Hermann W, Kluge R, et al. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. Am J Neuroradiol 2003; 24: 234-238.
25. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002; 59: 585-589.
26. Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL. Parkinsonism with excessive daytime sleepiness. A narcolepsy-like disorder?. J Neurol 2005; 252: 139-145.
27. Guilleminault C, Lee JH, Arias V. Cataplexy. In: Bassetti C, Billiard M, Mignot E eds. Narcolepsy and Hypersomnia. New York: Informa healtcare, 2007: 49-62.